Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VizionfocusTPE:4771 -0.49%91 Pretax Margin % is 31.69% as of Dec. 2025, which is 44% above its 10-year median of 22.01. GuruFocus rates TPE:4771 with a GF Score™ of 91/100 and a GF Value™ of NT$294.76 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Vizionfocus ranks better than 92.9% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vizionfocus's Pre-Tax Income for the
three
months ended in Dec. 2025 was NT$301 Mil. Vizionfocus's Revenue for the
three
months ended in Dec. 2025 was NT$951 Mil. Therefore, Vizionfocus's pretax margin for the quarter that ended in Dec. 2025 was 31.69%.
The historical rank and industry rank for Vizionfocus's Pretax Margin % or its related term are showing as below:
TPE:4771'
s Pretax Margin % Range Over the Past 10 Years
Min: -3.6 Med: 22.01 Max: 32.44
Current: 28.94
TPE:4771's Pretax Margin % is ranked better than 92.9% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs TPE:4771: 28.94
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Vizionfocus Pretax Margin % Related Terms
Vizionfocus Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Vizionfocus's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4771 vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Vizionfocus's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vizionfocus Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vizionfocus's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Vizionfocus's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vizionfocus (TPE:4771) has a Pretax Margin % of 31.69% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vizionfocus and its competitors. This is 44% above median its historical median of 22.01. According to the industry distribution chart, Vizionfocus ranks #58 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 7.1%.
Is Vizionfocus' Pretax Margin % too high?
Vizionfocus' current Pretax Margin % of 31.69% is 44% above median its 10-year median of 22.01. The Medical Devices & Instruments industry median Pretax Margin % is 2.61. Vizionfocus' value of 31.69% is 1114.2% above this industry median. Based on the distribution chart, Vizionfocus ranks #58 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vizionfocus has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vizionfocus' Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Vizionfocus ranks #58 out of 817 companies for Pretax Margin %. This places Vizionfocus in the top 7% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.61. Vizionfocus' value of 31.69% is 1114.2% above this benchmark. While the company's 10-year median is 22.01 vs. the industry median of 2.61, Vizionfocus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vizionfocus's current Pretax Margin % of 31.69% is 1114.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vizionfocus and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vizionfocus's current Pretax Margin % is 31.69%, which is 44% above median its own 10-year median of 22.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vizionfocus stock overvalued right now?
Based on GuruFocus' analysis, Vizionfocus (TPE:4771) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$294.76, compared to a current price of NT$203.00 — trading 31.1% below its estimated fair value. The current Pretax Margin % is 31.69%, which is 44% above median its 10-year median of 22.01 and 1114.2% above the Medical Devices & Instruments industry median of 2.61. Vizionfocus' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Vizionfocus (TPE:4771), the current Pretax Margin % is 31.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vizionfocus (TPE:4771) Overvalued in 2026?
Based on GuruFocus' analysis, Vizionfocus stock appears to be undervalued.
The current stock price of NT$203.00 is trading 31.1% below its estimated GF Value™ of NT$294.76.
GuruFocus considers Vizionfocus to be Significantly Undervalued.
Key valuation signals for TPE:4771:
Pretax Margin %: 31.69% (44% above median its 10-year median of 22.01)
GF Value™: NT$294.76 vs. price of NT$203.00 (31.1% below fair value)
Industry Position: 1114.2% above the Medical Devices & Instruments median (#58 of 817)
No single metric tells the full story. See the TPE:4771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vizionfocus Inc is mainly engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services. The Company operates through the VIZIONFOCUS segment, which generates maximum revenue and is engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services, and the Jiangsu Vizionfocus Inc. segment, whose main business includes the research and development, design, and production of contact lenses, as well as the wholesale, import, and export of related products.
91GF Score
Get the complete analysis for TPE:4771
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4771 has been successfully added to your 
